Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
132.4 USD | +1.37% | +3.57% | +15.77% |
Apr. 26 | Wolfe Adjusts Price Target on Xylem to $145 From $143 | MT |
Apr. 22 | RBC Capital Adjusts Xylem Price Target to $157 From $153 | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 39.34 times its estimated earnings per share for the ongoing year.
- The company's enterprise value to sales, at 3.85 times its current sales, is high.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Industrial Machinery & Equipment
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+15.77% | 32.01B | A | ||
+11.73% | 82.35B | A- | ||
+20.17% | 71.09B | B | ||
+20.89% | 37.72B | B- | ||
+9.19% | 27.2B | B- | ||
+3.18% | 26.74B | C+ | ||
+4.22% | 26B | B+ | ||
+16.93% | 25.5B | B+ | ||
+17.14% | 24.76B | B | ||
+17.30% | 17.84B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- XYL Stock
- Ratings Xylem Inc.